Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype
- PMID: 8774479
- DOI: 10.1002/(SICI)1096-9896(199607)179:3<254::AID-PATH589>3.0.CO;2-J
Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype
Abstract
Bronchioloalveolar carcinoma (BAC) is a form of peripheral lung adenocarcinoma growing as a single layer of malignant cells along the walls of terminal airways. The existence of BAC as a separate clinico-pathological entity has been a matter of controversy, mainly because its histogenesis is uncertain and it is not easily distinguishable from conventional lung adenocarcinoma (CLA). Three subtypes of BAC have been described using histological and cytological criteria: mucinous, non-mucinous, and sclerosing. The clinical behaviour of BAC appears to be dependent on the histological subtype. The different morphological patterns and clinical outcome of the subtypes of BAC suggest that their biological behaviour may be different from one another and from CLA. This study has investigated 58 BACs (10 mucinous, 40 non-mucinous, and 8 sclerosing) and 50 control CLAs for mutations at codon 12 of the K-ras oncogene. Twenty-one (36 per cent) BACs and 13 (26 per cent) CLAs showed K-ras mutations. A clear association (P < 0.0001) between K-ras mutations and the mucinous type of BAC was observed: all 10 mucinous tumours examined were scored positive for mutations in the K-ras gene, while only 9 (23 per cent) of the 40 non-mucinous and 2 (25 per cent) of the 8 sclerosing BACs were found to be positive. The frequency of ras mutations in non-mucinous BAC, sclerosing BAC, and CLA was not statistically different. Our data indicate that BACs are a heterogeneous group of lung tumours and that the mucinous form might represent a biological entity separate from both the other two BAC types and CLA.
Similar articles
-
FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.J Pathol. 1998 Mar;184(3):240-6. doi: 10.1002/(SICI)1096-9896(199803)184:3<240::AID-PATH20>3.0.CO;2-B. J Pathol. 1998. PMID: 9614374
-
Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.Am J Clin Pathol. 2007 Jul;128(1):100-8. doi: 10.1309/WVXFGAFLAUX48DU6. Am J Clin Pathol. 2007. PMID: 17580276
-
Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.Am J Surg Pathol. 2007 Jun;31(6):961-9. doi: 10.1097/01.pas.0000249444.90594.27. Am J Surg Pathol. 2007. PMID: 17527088
-
Bronchioloalveolar carcinoma: the case for two diseases.Clin Lung Cancer. 2008 Jan;9(1):24-9. doi: 10.3816/CLC.2008.n.004. Clin Lung Cancer. 2008. PMID: 18282354 Review.
-
Mucinous bronchioloalveolar carcinoma with K-ras mutation arising in type 1 congenital cystic adenomatoid malformation: a case report with review of the literature.Int J Clin Exp Pathol. 2013 Oct 15;6(11):2597-602. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24228126 Free PMC article. Review.
Cited by
-
Quantitative features of dual-energy spectral computed tomography for solid lung adenocarcinoma with EGFR and KRAS mutations, and ALK rearrangement: a preliminary study.Transl Lung Cancer Res. 2019 Aug;8(4):401-412. doi: 10.21037/tlcr.2019.08.13. Transl Lung Cancer Res. 2019. PMID: 31555515 Free PMC article.
-
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.Arch Pathol Lab Med. 2009 Mar;133(3):470-7. doi: 10.5858/133.3.470. Arch Pathol Lab Med. 2009. PMID: 19260752 Free PMC article.
-
Pros: the present classification of mucinous adenocarcinomas of the lung.Transl Lung Cancer Res. 2017 Apr;6(2):230-233. doi: 10.21037/tlcr.2017.04.11. Transl Lung Cancer Res. 2017. PMID: 28529905 Free PMC article. No abstract available.
-
Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia.Am J Pathol. 2006 Nov;169(5):1550-66. doi: 10.2353/ajpath.2006.051068. Am J Pathol. 2006. PMID: 17071580 Free PMC article.
-
Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO).Cancer Causes Control. 2011 Jan;22(1):73-9. doi: 10.1007/s10552-010-9676-5. Epub 2010 Nov 12. Cancer Causes Control. 2011. PMID: 21072579 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous